Biliary atresia other imaging findings

Biliary atresia Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Biliary atresia from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Biliary atresia other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Biliary atresia other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Biliary atresia other imaging findings
CDC on Biliary atresia other imaging findings
Biliary atresia other imaging findings in the news
Blogs on Biliary atresia other imaging findings
Directions to Hospitals Treating Biliary atresia
Risk calculators and risk factors for Biliary atresia other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief:Saud Khan M.D.

Other Imaging Findings

Nuclear medicine (hepatobiliary (HIDA) scan)

Cases of biliary atresia typically demonstrate relatively good hepatic uptake with no evidence of excretion into the bowel at 24 hours. Pretreatment with phenobarbital (5 mg/kg/day for 5 days) is done to stimulate hepatic enzymes in order to increase biliary secretion. This is helpful to minimize the possibility of a false-positive study due to pre-existing poor excretion. Radiotracers used are Tc-99m diosgenin (DISIDA) and mebrofenin (BRIDA) due to high hepatic extraction and short transit time.

Further testing include radioactive scans of the liver and a liver biopsy.